tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

KYTX Stock Latest News

RatingsKyverna Therapeutics, Inc.: Strategic Developments and Promising Clinical Trials Drive Buy Rating
7d ago
KYTX
PremiumRatings
Kyverna Therapeutics’ KYV-101 Program Shows Promising Developments and Advances in Clinical Trials
8d ago
KYTX
PremiumRatings
Kyverna Therapeutics’ KYV-101: Promising Data and Strategic Pathway Drive Buy Rating
11d ago
KYTX
Kyverna Therapeutics price target raised to $10 from $5 at H.C. Wainwright
PremiumThe Fly
Kyverna Therapeutics price target raised to $10 from $5 at H.C. Wainwright
11d ago
KYTX
PremiumRatings
Kyverna Therapeutics’ KYV-101: A Promising Investment in Addressing Unmet Needs in SPS and gMG
12d ago
KYTX
Kyverna Therapeutics to host KOL event on neuroimmunology CAR T franchise
PremiumThe FlyKyverna Therapeutics to host KOL event on neuroimmunology CAR T franchise
12d ago
KYTX
Kyverna Therapeutics initiated with an Outperform at William Blair
Premium
The Fly
Kyverna Therapeutics initiated with an Outperform at William Blair
20d ago
KYTX
Premium
Ratings
Kyverna Therapeutics: Promising Potential in Immune Cell Therapies with KYV-101
20d ago
KYTX
PremiumRatings
Kyverna Therapeutics: Promising Clinical Progress and Strategic Advancements Drive Buy Rating
25d ago
KYTX
PremiumRatings
Kyverna Therapeutics: Attractive Risk-Reward Profile with Upcoming Catalysts and Discounted Valuation
27d ago
KYTX
PremiumCompany Announcements
Kyverna Therapeutics Advances CAR T-Cell Therapy Trials
27d ago
KYTX
PremiumRatings
Kyverna Therapeutics: Promising Advancements in Neuroimmunology and Strategic Positioning for Market Leadership
27d ago
KYTX
Kyverna Therapeutics reports Q2 EPS (97c), consensus ($1.04)
PremiumThe FlyKyverna Therapeutics reports Q2 EPS (97c), consensus ($1.04)
28d ago
KYTX
Premium
Company Announcements
Kyverna Therapeutics Appoints New Chief Financial Officer
2M ago
8K
KYTX
Kyverna Therapeutics names Marc Grasso, M.D., as CFO
Premium
The Fly
Kyverna Therapeutics names Marc Grasso, M.D., as CFO
2M ago
KYTX
PremiumCompany Announcements
Kyverna Therapeutics Holds 2025 Annual Stockholders Meeting
3M ago
8K
KYTX
Kyverna, Rocket, Teva, Fair Isaac, Oklo Trending by Analysts
PremiumWeekend Updates
Kyverna, Rocket, Teva, Fair Isaac, Oklo Trending by Analysts
3M ago
FICO
KYTX
PremiumRatings
Kyverna Therapeutics’ KYV-101: Promising Developments and First-to-Market Potential in Autoimmune Diseases
3M ago
KYTX
PremiumRatings
Kyverna Therapeutics: Buy Rating Backed by Promising Pipeline and Strong Financial Position
4M ago
KYTX
Kyverna Therapeutics upgraded to Buy from Neutral at H.C. Wainwright
PremiumThe FlyKyverna Therapeutics upgraded to Buy from Neutral at H.C. Wainwright
4M ago
KYTX
Premium
Ratings
Kyverna Therapeutics: Strong Clinical Progress and Regulatory Alignment Support Buy Rating
4M ago
KYTX
Premium
Company Announcements
Kyverna Therapeutics Reports Q1 2025 Progress and Outlook
4M ago
KYTX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >